1. Home
  2. FLGT vs NVTS Comparison

FLGT vs NVTS Comparison

Compare FLGT & NVTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • NVTS
  • Stock Information
  • Founded
  • FLGT 2011
  • NVTS 2014
  • Country
  • FLGT United States
  • NVTS United States
  • Employees
  • FLGT N/A
  • NVTS N/A
  • Industry
  • FLGT Medical Specialities
  • NVTS Semiconductors
  • Sector
  • FLGT Health Care
  • NVTS Technology
  • Exchange
  • FLGT Nasdaq
  • NVTS Nasdaq
  • Market Cap
  • FLGT 683.5M
  • NVTS 762.1M
  • IPO Year
  • FLGT 2016
  • NVTS N/A
  • Fundamental
  • Price
  • FLGT $18.34
  • NVTS $3.17
  • Analyst Decision
  • FLGT Hold
  • NVTS Buy
  • Analyst Count
  • FLGT 1
  • NVTS 8
  • Target Price
  • FLGT $22.00
  • NVTS $4.75
  • AVG Volume (30 Days)
  • FLGT 298.0K
  • NVTS 9.5M
  • Earning Date
  • FLGT 11-08-2024
  • NVTS 11-04-2024
  • Dividend Yield
  • FLGT N/A
  • NVTS N/A
  • EPS Growth
  • FLGT N/A
  • NVTS N/A
  • EPS
  • FLGT N/A
  • NVTS N/A
  • Revenue
  • FLGT $277,761,000.00
  • NVTS $91,381,000.00
  • Revenue This Year
  • FLGT N/A
  • NVTS $8.34
  • Revenue Next Year
  • FLGT $16.00
  • NVTS $5.50
  • P/E Ratio
  • FLGT N/A
  • NVTS N/A
  • Revenue Growth
  • FLGT N/A
  • NVTS 38.99
  • 52 Week Low
  • FLGT $16.56
  • NVTS $1.75
  • 52 Week High
  • FLGT $30.68
  • NVTS $8.44
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 41.26
  • NVTS 51.65
  • Support Level
  • FLGT $19.25
  • NVTS $3.10
  • Resistance Level
  • FLGT $21.36
  • NVTS $3.64
  • Average True Range (ATR)
  • FLGT 0.88
  • NVTS 0.52
  • MACD
  • FLGT -0.11
  • NVTS -0.09
  • Stochastic Oscillator
  • FLGT 0.66
  • NVTS 22.44

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.

Share on Social Networks: